Epilepsy trials in Portugal

7 of 7 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Portugal
  Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

  Where

  Almada, Braga, Lisbon, Santa Maria Da Feira

  Age

  18 years to 75 years

  People

  333 worldwide

  Run by

  Rapport Therapeutics Inc.

  See details and how to joinNCT07563881 · EU 2025-524847-11-01
• Phase 3Taking people
  Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  Where

  Almada, Lisbon, Porto

  Age

  4 years to 55 years

  People

  252 worldwide

  Run by

  SK Life Science, Inc.

  See details and how to joinNCT05219617
• Phase 3Taking people
  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  Where

  Coimbra, Guimarães, Lisbon, Santa Maria Da Feira, Senhora Da Hora

  Age

  12 years and over

  People

  160 worldwide

  Run by

  Xenon Pharmaceuticals Inc.

  See details and how to joinNCT05667142 · EU 2022-502286-16-00
• Phase 3Completed
  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  Where

  Coimbra, Guimarães, Lisbon, Porto, Santa Maria Da Feira, Senhora Da Hora, Vila Real

  Age

  18 years and over

  People

  360 worldwide

  Run by

  Xenon Pharmaceuticals Inc.

  See details and how to joinNCT05716100 · EU 2022-502281-25-00
• Phase 3Taking people
  An Open-label Study of XEN1101 in Epilepsy

  Where

  Coimbra, Guimarães, Lisbon, Porto, Santa Maria Da Feira, Senhora Da Hora, Vila Real

  Age

  12 years and over

  People

  880 worldwide

  Run by

  Xenon Pharmaceuticals Inc.

  See details and how to joinNCT05718817 · EU 2022-502282-24-00
• Phase 3Enrolling by invitation
  A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

  Where

  Coimbra, Lisbon, Porto

  Age

  2 years to 66 years

  People

  324 worldwide

  Run by

  Longboard Pharmaceuticals

  See details and how to joinNCT06908226 · EU 2024-514974-39-00
• Phase 2Taking people
  Long-term Safety and Tolerability of BHV-7000

  Where

  Braga, Coimbra, Lisbon, Matosinhos, Santa Maria Da Feira

  Age

  18 years to 75 years

  People

  660 worldwide

  Run by

  Biohaven Therapeutics Ltd.

  See details and how to joinNCT06443463 · EU 2023-508813-18-00